Radioimmunoassay of serum medroxyprogesterone acetate (Provera ®) in women following oral and intravaginal administration
Authors:
- M. HiroiMHM. Hiroi
- F.Z. StanczykFSF.Z. Stanczyk
- U. GoebelsmannUGU. Goebelsmann
- P.F. BrennerPBP.F. Brenner
- M.E. LumkinMLM.E. Lumkin
- D.R. MishellDMD.R. Mishell
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Return of ovulatory cyclicity following an intramuscular injection of medroxyprogesterone acetate (Provera)Contraception, 1974
- Radioimmunoassay for medroxyprogesterone acetate (Provera®) using the 11α-hydroxy succinyl conjugateSteroids, 1974
- GLC Determination of Medroxyprogesterone Acetate in PlasmaJournal of Pharmaceutical Sciences, 1974
- Inhibition of ovulation with cyclic use of progestogen-impregnated intravaginal devicesAmerican Journal of Obstetrics and Gynecology, 1972
- Radioimmunoassay of serum progesterone in women receiving oral contraceptive steroidsContraception, 1972
- Serum gonadotropin and steroid patterns during the normal menstrual cycleAmerican Journal of Obstetrics and Gynecology, 1971
- Measurement of Medroxyprogesterone Acetate (Provera) by Radioimmunoassay1The Journal of Clinical Endocrinology & Metabolism, 1971
- Contraceptive Effect of Varying Dosages of Progestogen in Silastic Vaginal RingsFertility and Sterility, 1970